The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicines" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of medicinalof the preparation (registration certificate LP-002670 dated 10/22/2014 issued Joint Stock Company "R-Pharm" (JSC "R-Pharm"):
Beyodeim® (trade name of the medicinal product)
Pertuzumab + Trastuzumab [set] (international non-proprietary or grouping or chemical name)
set: concentrate for solution for infusion, (Perieta® (pertuzumab)); lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, (Herceptin® (trastuzumab)), 420 mg / 14 ml + 440 mg (dosage form, dosage)
Joint Stock Company "ORTAT" (JSC "ORTAT"), Russia 157092, Kostroma region, Susaninsky district, with. Northern, md. Kharitonovo (name and address of the location of the manufacturer of the medicinal product)
on the basis of an application by the authorized legal entity of R-Pharm JSC to cancel the state registration of the medicinal product.